1 INTRODUCTION
1.1 OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.3 RESEARCH METHODOLOGY
1.3.1 SECONDARY DATA
1.3.2 PRIMARY DATA
1.3.3 MARKET SIZE ESTIMATION
1.3.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.4 STAKEHOLDERS
1.5 CURRENCY
1.6 RESEARCH ASSUMPTIONS
1.7 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 DROC MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 COST STRUCTURE ANALYSIS
3.6 VALUE CHAIN ANALYSIS
3.7 COVID-19 IMPACT ANALYSES
4 INDUSTRY TRENDS
4.1 INTRODUCTION
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES MODEL
4.3.1 DEGREE OF COMPETITION
4.3.2 BARGAINING POWER OF BUYERS
4.3.3 BARGAINING POWER OF SUPPLIERS
4.3.4 THREAT FROM SUBSTITUTES
4.3.5 THREAT FROM NEW ENTRANTS
5 MEDICAL CANNABIS TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2015-2019
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 ТЕTRАHУDRОСАNNАBІNОL (ТНС)
5.6 САNNАBІDІОL (СВD)
6 MEDICAL CANNABIS MARKET SPECIES ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET SPECIES ANALYSIS, 2015-2019
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 INDICA
6.6 SATIVA
6.7 HYBRID
7 MEDICAL CANNABIS MARKET DERIVATIVES ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET DERIVATIVES ANALYSIS, 2015-2019
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 CANNABIDIOL (CBD)
7.6 TETRAHYDROCANNABINOL (THC)
7.7 OTHERS
8 MEDICAL CANNABIS MARKET END-USE ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET END-USE ANALYSIS, 2015-2019
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 PHARMACEUTICAL INDUSTRY
8.6 RESEARCH AND DEVELOPMENT CENTRES
8.7 OTHERS
9 MEDICAL CANNABIS MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 РАІN
9.6 АRTHRІTІЅ
9.7 CANCER
9.8 NЕURОLОGІСАL DІЅЕАЅЕ (ЕРІLЕРЅУ, МULTІРLЕ ЅСLЕRОЅІЅ АND ОTHЕR NЕURОLОGІСАL АРРLІСАTІОNЅ)
9.9 ОTHЕRЅ
10 GLOBAL MEDICAL CANNABIS REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 SOUTH AMERICA
10.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 ВОL РHАRMА
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 ТІLRАУ
11.3 МЕDRЕLЕАF СОRРОRАTІОN
11.4 АURОRА САNNАBІЅ, ІNС
11.5 САNОРУ GRОWTH СОRРОRАTІОN
11.6 ІNЅУЅ ТHЕRАРЕUTІСЅ, ІNС
11.7 АРHRІА, ІNС
11.8 МGС РHАRMАСЕUTІСАLЅ LІMІTЕD
11.9 GW РHАRMАСЕUTІСАLЅ, РLС
11.10 МЕDІСАL МАRІЈUАNА ІNС
11.11 CANNIMED THERAPEUTICS INC
11.12 CARA THERAPEUTICS INC
11.13 UNITED CANNABIS CORPORATION
12 ABOUT US

TABLE 1 MEDICAL CANNABIS REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 2 GLOBAL MEDICAL CANNABIS MARKET, 2020–2030, (USD MILLION)
TABLE 3 MEDICAL CANNABIS CURRENT AND FUTURE REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 4 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 5 MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 6 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET SPECIES ANALYSIS, 2015-2019, (USD MILLION)
TABLE 7 MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 8 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET DERIVATIVES ANALYSIS, 2015-2019, (USD MILLION)
TABLE 9 MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 10 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET END-USE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 11 MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 12 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 13 MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 14 NORTH AMERICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 15 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 16 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 17 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 18 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 19 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 20 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2015–2020
TABLE 21 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 22 U.S. MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 23 CANADA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 24 CANADA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 25 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 26 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 27 APAC MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 28 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 33 CHINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 34 CHINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 35 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 36 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 37 KOREA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 38 KOREA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 39 INDIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 40 INDIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 51 UAE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 52 UAE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 53 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 54 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 55 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 56 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 59 EUROPE MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 60 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 61 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 62 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 63 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 64 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 65 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 66 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 67 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 68 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 69 UK MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 70 UK MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 71 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 72 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 73 ITALY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 74 ITALY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 75 SOUTH AMERICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 76 SOUTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 77 SOUTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 78 SOUTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2020–2030 (USD MILLION)
TABLE 79 TABLE 82 SOUTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 80 SOUTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 81 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 82 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 83 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 84 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 85 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 86 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)